摘要
目的探讨动态监测脓毒性休克患者的血浆B型脑钠肽前体(Pro—BNP)浓度对脓毒性休克心功能抑制程度和患者预后的评估作用。方法测定102例脓毒性休克患者第1、3、5天血浆Pro-BNP浓度,根据28d存活情况分为存活组和死亡组,按血流动力学指标分为心功能减低组(CI〈3.0)和心功能正常组(CI≥3.0),分析其在各组之间的差异,并统计ICU病死率及28d病死率,分析Pro—BNP浓度对临床结局的预测价值。结果28d存活组人院第1、3、5天的血浆Pro-BNP浓度呈明显下降趋势[(1649.0±257.5)、(1867.6±291.7)、(1229.9±194.5)ng/L],而死亡组患者血浆Pro—BNP浓度则呈上升趋势[(4128.8±1051.1)、(5315.9±925.4)、(6899.9±1327.9)ng/L],两组第1、3、5天的血浆Pro—BNP浓度比较差异均有统计学意义(t值分别为3.057、5.083、6.290,P均〈0.01);心功能正常组患者28d病死率和人院第1、3、5天的Pro—BNP浓度明显低于心功能减低组[28d病死率:62.1%与20.0%;(1592.8±362.2)与(4556.6±732.7)ng/L,(2933.6±421.7)与(5768.5±793.7)ng/L,(3014.5±587.5)与(8873.9±1670.1)ng/L](x2=20.635,P=0.000,t值分别为.3.626、3.154、3.310,P均〈0.01)。以入院第5天的Pro—BNP浓度〉3053ng/L作为预测28d病死率的临界点,其敏感度为88.4%,特异度为91.5%;以入院第5天的Pro-BNP浓度〉2378ng/L作为预测住院病死率的临界点,其敏感度为84.9%,特异度为91.8%。多因素分析显示对于28d病死率APACHEII评分及第5天的Pro—BNP浓度是独立预测因素,第5天的Pro—BNP浓度是预测住院病死率的独立预测因素。结论动态监测血浆Pro-BNP浓度可以评价脓毒性休克患者的心脏抑制程度,入院第5天Pro—BNP浓度可以预测脓毒性休克患者的预后。
Objective To assess the effects of dynamic monitoring of plasma Pro-B-type Natriuretic Peptide(Pro-BNP) in the evaluation of prognostic value and myocardial dysfunction in patients with septic shock. Methods The levels of plasma Pro-BNP were tested in 102 patients with septic shock on the 1,3, and 5 days. Data on ICU mortality and 28-day mortality were collected. The patients were divided into non-dysfunction group ( CI 〈3.0) and cardiac dysfunction group (CI≥3.0) according to levels of hemodynamic variables ( CI level). The prognostic value of plasma Pro-BNP was analyzed. Results Plasma Pro-BNP levels on the 1,3 and 5 days in 28-day survivors have a significant declining trend [ ( 1649. 0±257.5 ) ng/L, ( 1867.6 ± 291.7 ) ng/L vs. (1229. 9± 194. 5 ) ng/L ), while plasma Pro-BNP levels in non-survivors have an increasing trend [ (4128.8±1051.1 ), ( 5315.9 ±925.4 ) vs. ( 6899. 9± 1327.9 ) ng/L ]. There is statistical significance of plasma Pro-BNP levels at day 1,3 and 5 for the two groups ( t = 3.057,5.083, and 6. 290 respectively, P 〈 0. 01 ). The 28-day mortality and Plasma Pro-BNP levels in cardiac dysfunction group were higher than of non- dysfunction group ( 28-day mortality : 62. 1% vs. 20. 0% ; Pro-BNP1 : ( 1592. 8 ±362. 2 )ng/L vs. (4556. 6 ± 732. 7) ng/L; Pro-BNP3 : ( 2933.6 ± 421.7 ) vs. (5768.5 ± 793.7 ) ng/L, Pro-BNP5 : ( 3014. 5 ± 587. 5 ) ng/L vs. (8873.9 ± 1670. 1 ) ng/L (X2 = 20. 635, P = 0. 000, t = 3. 626,3. 154,3. 310, P 〈 0. O1 ]. Pro-BNP level greater than 3053 ng/L on the 5-day was an independent prognostic indicator of 28-day mortality ( sensitivity : 88.4% ;specificity :91.5% ). Pro-BNP level greater than 2378 ng/L on the 5-day was an independent prognostic indicator of hospital mortality ( sensitivity: 84. 9% ; specificity: 91.8% ) . In multivariate logistic regression analyses,Pro-BNP level and APACHE score were independent predictors of 28-day mortality and hospital mortality. Conclusion Plasma Pro-BNP level shows obvious significance in evaluation of sepsis-induced myocardial depression severity in patients with septic shock. Pro-BNP level in ICU at day 5 after inclusion is an independent prognostic marker of mortality in septic shock.
出处
《中国综合临床》
2012年第12期1268-1272,共5页
Clinical Medicine of China
基金
北京市教育委员会科技发展基金(kin200710025027)
关键词
脓毒性休克
B型钠尿肽前体
预后
Septic shock
Pro-B-type natriuretic peptide
Prognosis